CNSP

CNS Pharmaceuticals, Inc.

Healthcare · Biotechnology

$323.09 sample

+2.88 (+0.90%) 1D

Market cap

$1.45T

Price as of

2026-10-04

Latest filing

8-K · 2026-09-29

Alerts

8

Price$323.09 +12.77% 3M daily closessample

323.28283.04

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 29SECDEF 14A filed
Sep 23INSInsider sell: EVP, Operations
Sep 14INSInsider sell: Chief Executive Officer
Sep 08INSInsider sell: Director
Sep 01INSInsider sell: 10% owner
Aug 26INSInsider sell: General Counsel
Aug 20INSInsider sell: Chief Executive Officer
Aug 11INSInsider sell: EVP, Operations

Sign up to see the real CNSP record →

Company facts

SEC EDGAR registration

Name: CNS Pharmaceuticals, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -38sample, -100 to +100
Reporting currency: USD

Who is positioning in CNSP

sample

Insiders: 17 insider transactions over 90 days, net selling, $272.4M
Congress: 1 members traded over 90 days
Institutions · 13F: 30 funds hold $33.2B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$66.1B +20.9% y/y

Q4 2024Q3 2026

Inventory$37.5B +12.0% y/y

Q4 2024Q3 2026

Accounts receivable$29.3B +14.2% y/y

Q4 2024Q3 2026

Total debt$76.7B +10.1% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $442.4B +9.3% 3M
Sample peer B: $756.9B -3.7% 3M
Sample peer C: $801.9B -0.1% 3M
Sample peer D: $230.1B -6.4% 3M
Sample peer E: $637.1B +9.2% 3M